Last reviewed · How we verify

Standard early enteral nutrition

Jinling Hospital, China · FDA-approved active Small molecule

Standard early enteral nutrition is a Small molecule drug developed by Jinling Hospital, China. It is currently FDA-approved for Nutritional support in critically ill patients, Post-operative nutritional management, Trauma and burn patients requiring metabolic support.

Standard early enteral nutrition provides essential nutrients directly into the gastrointestinal tract to support metabolic needs and maintain gut barrier function during critical illness or post-operative recovery.

Standard early enteral nutrition provides essential nutrients directly into the gastrointestinal tract to support metabolic needs and maintain gut barrier function during critical illness or post-operative recovery. Used for Nutritional support in critically ill patients, Post-operative nutritional management, Trauma and burn patients requiring metabolic support.

At a glance

Generic nameStandard early enteral nutrition
SponsorJinling Hospital, China
ModalitySmall molecule
Therapeutic areaCritical Care / Nutrition Support
PhaseFDA-approved

Mechanism of action

Early enteral nutrition (EEN) delivers calories, proteins, and micronutrients via the GI tract (oral, nasogastric, or post-pyloric routes) rather than parenteral means. This approach preserves gut mucosal integrity, maintains beneficial microbiota, reduces bacterial translocation, and supports immune function. EEN is a clinical nutritional intervention rather than a pharmacological agent, designed to optimize patient outcomes in critical care and surgical settings.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Standard early enteral nutrition

What is Standard early enteral nutrition?

Standard early enteral nutrition is a Small molecule drug developed by Jinling Hospital, China, indicated for Nutritional support in critically ill patients, Post-operative nutritional management, Trauma and burn patients requiring metabolic support.

How does Standard early enteral nutrition work?

Standard early enteral nutrition provides essential nutrients directly into the gastrointestinal tract to support metabolic needs and maintain gut barrier function during critical illness or post-operative recovery.

What is Standard early enteral nutrition used for?

Standard early enteral nutrition is indicated for Nutritional support in critically ill patients, Post-operative nutritional management, Trauma and burn patients requiring metabolic support.

Who makes Standard early enteral nutrition?

Standard early enteral nutrition is developed and marketed by Jinling Hospital, China (see full Jinling Hospital, China pipeline at /company/jinling-hospital-china).

What development phase is Standard early enteral nutrition in?

Standard early enteral nutrition is FDA-approved (marketed).

What are the side effects of Standard early enteral nutrition?

Common side effects of Standard early enteral nutrition include Diarrhea, Aspiration risk, Abdominal distension, Feeding intolerance.

Related